Andere Kunden interessierten sich auch für
![Intellectual Property Issues]( "Intellectual Property Issues")
Intellectual Property Issues55,99 €![Alginates: Biology and Applications]( "Alginates: Biology and Applications")
Alginates: Biology and Applications116,99 €![Emerging Trends in Cell and Gene Therapy]( "Emerging Trends in Cell and Gene Therapy")
Emerging Trends in Cell and Gene Therapy148,99 €![Cyclic ¿-Glucans from Microorganisms]( "Cyclic ¿-Glucans from Microorganisms")
Cyclic ¿-Glucans from Microorganisms37,99 €![Biomolecular Interfaces]( "Biomolecular Interfaces")
Biomolecular Interfaces37,99 €![Hepatitis C Virus: From Molecular Virology to Antiviral Therapy]( "Hepatitis C Virus: From Molecular Virology to Antiviral Therapy")
Hepatitis C Virus: From Molecular Virology to Antiviral Therapy110,99 €![Survival Strategies in Extreme Cold and Desiccation]( "Survival Strategies in Extreme Cold and Desiccation")
Survival Strategies in Extreme Cold and Desiccation148,99 €
Patents protecting biotechnological invention are becoming ever more important. Because biotechnology has many differences with respect to other technologies, lessons learned in other fields of technology cannot simply be transferred to adopt a suitable strategy for dealing with biotechnology inventions.
In this volume, general aspects of biopatent law will be discussed. This involves questions of patentability, including ethical issues and issues of technicality, as well as questions of patent exhaustion in cases were reproducible subject matter, like cells or seeds, is protected. Moreover, active and passive patent strategies are addressed. Further, insight will be given into patent lifetime management and additional protective measures, like supplementary protection certificates and data exclusivity. Here, strategies are discussed how market exclusivity can be extended as long as possible, which is particularly important for biopharmaceutical drugs, which create high R&D costs.
In this volume, general aspects of biopatent law will be discussed. This involves questions of patentability, including ethical issues and issues of technicality, as well as questions of patent exhaustion in cases were reproducible subject matter, like cells or seeds, is protected. Moreover, active and passive patent strategies are addressed. Further, insight will be given into patent lifetime management and additional protective measures, like supplementary protection certificates and data exclusivity. Here, strategies are discussed how market exclusivity can be extended as long as possible, which is particularly important for biopharmaceutical drugs, which create high R&D costs.